Pacer Advisors, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Pacer Advisors, Inc.

  • $41.8 Billion
  • Q3 2024

A detailed history of Pacer Advisors, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Pacer Advisors, Inc. holds 19,540 shares of REGN stock, worth $13.7 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
19,540
Previous 16,464 18.68%
Holding current value
$13.7 Million
Previous $17.3 Million 18.71%
% of portfolio
0.05%
Previous 0.04%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$1024.09 - $1201.76 $3.15 Million - $3.7 Million
3,076 Added 18.68%
19,540 $20.5 Million
Q2 2024

Aug 13, 2024
BUY
$883.2 - $1071.19 $1.27 Million - $1.54 Million
1,434 Added 9.54%
16,464 $17.3 Million
Q1 2024

May 10, 2024
BUY
$902.69 - $993.35 $816,031 - $897,988
904 Added 6.4%
15,030 $14.5 Million
Q4 2023

Jan 16, 2024
BUY
$775.18 - $881.7 $1.43 Million - $1.63 Million
1,845 Added 15.02%
14,126 $12.4 Million
Q3 2023

Nov 13, 2023
BUY
$692.45 - $844.37 $1.11 Million - $1.36 Million
1,608 Added 15.07%
12,281 $10.1 Million
Q2 2023

Jul 12, 2023
SELL
$700.03 - $830.35 $1.65 Million - $1.96 Million
-2,362 Reduced 18.12%
10,673 $7.67 Million
Q1 2023

May 02, 2023
BUY
$680.49 - $826.97 $4.63 Million - $5.63 Million
6,810 Added 109.4%
13,035 $10.7 Million
Q4 2022

Feb 06, 2023
SELL
$705.89 - $766.39 $181 Million - $197 Million
-256,440 Reduced 97.63%
6,225 $4.49 Million
Q3 2022

Oct 18, 2022
BUY
$573.97 - $724.32 $24.1 Million - $30.4 Million
41,988 Added 19.03%
262,665 $181 Million
Q2 2022

Aug 12, 2022
BUY
$548.35 - $738.84 $52.3 Million - $70.4 Million
95,310 Added 76.02%
220,677 $130 Million
Q1 2022

Apr 05, 2022
BUY
$595.12 - $698.43 $45.4 Million - $53.3 Million
76,354 Added 155.78%
125,367 $87.6 Million
Q4 2021

Feb 03, 2022
BUY
$543.48 - $670.97 $21.1 Million - $26.1 Million
38,907 Added 384.99%
49,013 $31 Million
Q3 2021

Oct 15, 2021
SELL
$574.03 - $680.96 $265,775 - $315,284
-463 Reduced 4.38%
10,106 $6.12 Million
Q2 2021

Jul 21, 2021
BUY
$472.8 - $558.54 $228,835 - $270,333
484 Added 4.8%
10,569 $5.9 Million
Q1 2021

Apr 05, 2021
SELL
$446.73 - $548.2 $234,979 - $288,353
-526 Reduced 4.96%
10,085 $4.77 Million
Q4 2020

Jan 20, 2021
SELL
$478.3 - $607.98 $2.5 Million - $3.17 Million
-5,218 Reduced 32.96%
10,611 $5.13 Million
Q3 2020

Oct 19, 2020
SELL
$544.75 - $658.21 $847,631 - $1.02 Million
-1,556 Reduced 8.95%
15,829 $8.86 Million
Q2 2020

Jul 29, 2020
BUY
$493.32 - $643.92 $4.25 Million - $5.55 Million
8,625 Added 98.46%
17,385 $10.8 Million
Q1 2020

Apr 23, 2020
BUY
$336.18 - $494.43 $86,398 - $127,068
257 Added 3.02%
8,760 $4.98 Million
Q4 2019

Feb 10, 2020
SELL
$274.13 - $376.51 $5.8 Million - $7.97 Million
-21,171 Reduced 71.35%
8,503 $3.19 Million
Q3 2019

Oct 10, 2019
BUY
$273.46 - $318.39 $671,070 - $781,329
2,454 Added 9.02%
29,674 $8.23 Million
Q2 2019

Aug 12, 2019
BUY
$299.6 - $414.82 $4.25 Million - $5.89 Million
14,194 Added 108.97%
27,220 $8.52 Million
Q1 2019

Apr 10, 2019
BUY
$372.08 - $439.57 $4.85 Million - $5.73 Million
13,026 New
13,026 $5.35 Million
Q4 2018

Feb 13, 2019
SELL
$335.82 - $403.04 $3.04 Million - $3.64 Million
-9,038 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$351.14 - $408.51 $703,333 - $818,245
2,003 Added 28.47%
9,038 $3.65 Million
Q2 2018

Aug 14, 2018
BUY
$284.6 - $344.99 $358,026 - $433,997
1,258 Added 21.78%
7,035 $2.43 Million
Q1 2018

May 14, 2018
BUY
$315.82 - $393.78 $276,026 - $344,163
874 Added 17.83%
5,777 $1.99 Million
Q4 2017

Feb 14, 2018
BUY
$358.63 - $469.95 $543,683 - $712,444
1,516 Added 44.76%
4,903 $1.84 Million
Q3 2017

Nov 08, 2017
BUY
$431.38 - $504.0 $1.46 Million - $1.71 Million
3,387
3,387 $1.51 Million

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Pacer Advisors, Inc. Portfolio

Follow Pacer Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email